MYO TECHNOLOGY Logo (WIPO, 29.04.2021)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MYO TECHNOLOGY wurde als Bildmarke am 29.04.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Andere geometrische Figuren, undefinierbare Designs #Briefe, die eine besondere Form des Schreibens darstellen #Buchstabenreihen in verschiedenen Dimensionen
| Markenform | Bildmarke |
| Aktenzeichen | 1600080 |
| Länder | 
|
| Basismarke |
Nr. 90289629,
30. Oktober 2020
|
| Anmeldedatum | 29. April 2021 |
| Ablaufdatum | 29. April 2031 |
Markeninhaber
30-02 48th Avenue
Long Island City NY 11101
US
Long Island City NY 11101
US
Markenvertreter
Morgan, Lewis & Bockius LLP,
One Federal Street
US
Waren und Dienstleistungen
05
Pharmaceutical preparations containing nucleic acid
sequences that encode monoclonal antibodies for the
treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders; pharmaceutical compositions for the prevention
and treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders; nucleic acid sequences for medical purposes;
pharmaceutical compositions, namely, a nucleotide sequence
that encodes an antigen, such as a DNA plasmid having an
antigen encoding sequence and like DNA, for the prevention
and treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders; pharmaceutical preparations for human use for the
treatment and prevention of cancer, autoimmune diseases,
rare diseases, infectious diseases, inflammatory diseases,
and blood disorders; pharmaceutical preparations for human
and veterinary use, namely, antibiotics, antifungals and
anti-virals; gene therapy and prophylactic products, namely,
gene delivery pharmaceuticals for the treatment of genetic
or cell based conditions
10
Medical apparatus for the administration of
biopharmaceuticals and vaccines, namely, drug delivery
devices and systems; medical devices, namely, for
electroporation mediated administration of drugs to humans
and animals; delivery systems for administration of
biopharmaceuticals and vaccines for the preventive or
treatment of disease in humans and animals; handheld medical
systems and devices using electroporation for the prevention
or treatment of cancer, autoimmune diseases, rare diseases,
infectious diseases, inflammatory diseases, and blood
disorders in humans and animals; handheld clinical delivery
systems and devices for the application of electrical fields
in tissue, in particular muscle and skin, in conjunction
with the administration of biopharmaceuticals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 18. Juli 2023 | 2023/29 Gaz | CA | Ablehnung |
| 25. Januar 2023 | 2023/5 Gaz | BR | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 10. November 2022 | 2022/46 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 04. Oktober 2022 | 2022/40 Gaz | CA | Ablehnung |
| 02. August 2022 | 2022/32 Gaz | BR | Ablehnung |
| 26. Mai 2022 | 2022/22 Gaz | JP | Ablehnung |
| 03. März 2022 | 2022/9 Gaz | GB | Ablehnung |
| 15. Februar 2022 | 2022/9 Gaz | IN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 01. Dezember 2021 | 2021/52 Gaz | CN | Ablehnung |
| 24. November 2021 | 2021/47 Gaz | EM | Ablehnung |
| 21. September 2021 | 2021/38 Gaz | AU | Ablehnung |
| 20. Juli 2021 | 2021/30 Gaz | IN | Ablehnung |
| 29. April 2021 | 2021/24 Gaz | US | Eintragung |
ID: 141600080